Seattle Genetics, Inc. (SGEN) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET
Company Participants
Peggy Pinkston – Vice President, Investor Relations
Clay Siegall – President and Chief Executive Officer
Chip Romp – Executive Vice President-Commercial
Todd Simpson – Chief Financial Officer
Roger Dansey – Chief Medical Officer
Conference Call Participants
Salveen Richter – Goldman Sachs
Kennen MacKay – RBC Capital Markets
Michael Schmidt – Guggenheim
Greg Harrison – Bank of America
Chad Messer – Needham & Company
Gena Wang – Barclays
Joe Catanzaro – Piper Jaffray
Andrew Berens – SVB
Stephen Willey – Stifel
George Farmer – BMO Capital Market
Andy Hsieh – William Blair
Silvan Tuerkcan – Oppenheimer
Operator
Good day and welcome to the Seattle Genetics First Quarter 2020 Financial Results Conference Call. Today’s call is being recorded.
At this time I would like to turn the conference over to Ms. Peggy Pinkston, Vice President of Investor Relations. Please go ahead.
Peggy Pinkston
Thank you, operator, and good afternoon, everyone. I’d like to welcome all of you to Seattle Genetics first quarter 2020 conference call. With me today are Clay Siegall, President and Chief Executive Officer; Chip Romp, Executive Vice President-Commercial, Todd Simpson, Chief Financial Officer; and Roger Dansey, Chief Medical Officer.
Accompanying today’s conference call are supporting slides, which are available on our website in the Investors section, Events and Presentations page. Following our prepared remarks, we’ll open the line for questions. [Operator Instructions]
Today’s conference call will include forward-looking statements regarding future or anticipated events and results, including the company’s 2020 financial outlook, anticipated product sales, revenues, costs and expenses, and timing to achieve potential clinical and regulatory milestones, including data readouts, regulatory submissions and approvals.
Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that
- Read more current SGEN analysis and news
- View all earnings call transcripts